IL6 and prostate carcinoma: Their antioxidant and anti-inflammatory properties help regulate lipid metabolism and reduce the production of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNFα), interleukin-1β, and interleukin-6 (IL-1β and IL-6) [18,19,20], exhibiting anti-proliferative effects on various cancer cells, including lung, colorectal, breast, and prostate cancer, and notably, melanoma [21,22,23,24].